Sanofi strikes Cheplapharm deal to divest 20 older medicines as CEO pushes for innovation

In a deal that allows Sanofi to shed assets wrapped up in mature products, German drugmaker Cheplapharm will take over 20 medicines and three manufacturing sites from Sanofi. In exchange, Sanofi is picking up a 26.4% stake in the company.